Stockholm - Delayed Quote SEK

Harm Reduction Group AB (NOHARM.ST)

Compare
0.0168
0.0000
(0.00%)
At close: January 28 at 10:04:42 AM GMT+1
Loading Chart for NOHARM.ST
DELL
  • Previous Close 0.0168
  • Open 0.0170
  • Bid --
  • Ask --
  • Day's Range 0.0168 - 0.0168
  • 52 Week Range 0.0100 - 0.2790
  • Volume 618,918
  • Avg. Volume 782,480
  • Market Cap (intraday) 6.955M
  • Beta (5Y Monthly) 1.20
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Harm Reduction Group AB (publ) provides legal nicotine products as a substitute for the harmful tobacco smoking. It also offers electronic cigarettes. The company offer its products under Norse, IVG, Aroma King, and other brands. It sells its products through physical stores, e-commerce, brands, and retail sales. The company was formerly known as Norse Impact AB (publ) and changed its name to Harm Reduction Group AB (publ) in July 2023. Harm Reduction Group AB (publ) was incorporated in 2012 is based in Gothenburg, Sweden.

harmreductiongroup.com

78

Full Time Employees

December 31

Fiscal Year Ends

Tobacco

Industry

Recent News: NOHARM.ST

View More

Performance Overview: NOHARM.ST

Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

NOHARM.ST
41.67%
OMX Stockholm 30 Index
6.31%

1-Year Return

NOHARM.ST
92.26%
OMX Stockholm 30 Index
12.02%

3-Year Return

NOHARM.ST
97.20%
OMX Stockholm 30 Index
15.85%

5-Year Return

NOHARM.ST
98.23%
OMX Stockholm 30 Index
42.70%

Compare To: NOHARM.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NOHARM.ST

View More

Valuation Measures

As of 2/6/2025
  • Market Cap

    6.95M

  • Enterprise Value

    24.32M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.04

  • Price/Book (mrq)

    0.17

  • Enterprise Value/Revenue

    0.17

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -24.77%

  • Return on Assets (ttm)

    -15.00%

  • Return on Equity (ttm)

    -74.31%

  • Revenue (ttm)

    162.34M

  • Net Income Avi to Common (ttm)

    -40.21M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.39M

  • Total Debt/Equity (mrq)

    36.69%

  • Levered Free Cash Flow (ttm)

    -21.93M

Research Analysis: NOHARM.ST

View More